Introducing viruses: acellular parasites

The optical limit. Viruses were found by a filter because a better microscope could not have found them. The resolving power of a light microscope is limited to about 200 nanometres, a ceiling fixed by the wavelength of visible light — roughly 400 to 700 nanometres — and described mathematically by Ernst Abbe in the 1870s. Magnifying beyond that limit produces empty magnification: a larger picture with no additional detail. Stains improve contrast, not resolution. Because most virions measure 20 to 250 nanometres, they lie below the optical limit, and no combination of lenses, immersion oil or dye could bring them into focus.

The filter that answered a different question. The Chamberland-Pasteur filter, introduced by Charles Chamberland in 1884 in Pasteur’s laboratory, was an unglazed porcelain candle whose pores, of the order of a fraction of a micrometre, held back bacteria and larger particles by simple size exclusion. Filtration therefore answered a question that optics could not even pose: it turned the problem into a test of passage. If the clear filtrate was still infectious, then the agent had either squeezed through pores too fine for any bacterium or the filtrate was contaminated, and careful controls and repetition could separate those two explanations. Ivanowski, in 1892, remained cautious and did not claim a new class of organism, suspecting a very small bacterium or a fault in his filter. This is why the filter mattered: it detected a property — passing a bacteria-tight barrier — that no image could show, and it made the experiment scoreable with the naked eye, because the observer watched the plant and not the particle.

Why a clear filtrate is not sterile. That same property later became a warning as well as a tool: filtration removes bacteria and larger particles but does not remove viruses, mycoplasmas or toxins, so a filtrate is not sterile in the full sense.

Ivanowski had shown that the agent passed a bacteria-tight filter, but he left its nature open; the word virus then meant a poison or a contagious principle, not a kind of particle. Martinus Beijerinck, working on tobacco mosaic disease in 1898, supplied the missing argument. He showed that the infectious principle diffused through a block of agar, that repeated dilution and passage through many plants did not weaken it as it would weaken a chemical toxin, and that it could not be cultivated on nutrient media: it multiplied only in living, dividing plant tissue. From those behaviours he named it contagium vivum fluidum, a contagious living fluid, and revived the word virus for it. The importance is methodological, and it still shapes the subject. Beijerinck defined the new category by what the agent did rather than by how small it looked — filterable, invisible, not cultivable in broth or on agar, dependent on living tissue — and that is the definition that made a separate class of organism defensible. Wendell Stanley added the chemistry in 1935, when he obtained crystals of tobacco mosaic virus, an achievement that contributed to his 1946 Nobel Prize. Stanley first argued that the infectious material was a pure protein; in 1936 Norman Bawden and William Pirie showed that the crystals contained both protein and ribonucleic acid, so the genome was RNA and the particle was a nucleoprotein. That chemical result closed the argument: the agent was not merely a small bacterium, because a bacterium cannot be crystallised in this way and has a different chemical composition. Bacteriophages were discovered soon afterwards — Frederick Twort in 1915 and Félix d’Hérelle in 1917 — and in 1952 Alfred Hershey and Martha Chase used phage T2 to show that DNA, not protein, carries genetic information. The clinical inheritance is direct. Because a virus cannot be seen and cannot be grown on ordinary media, diagnosis moved to detecting its proteins (antigen tests), its nucleic acid (polymerase chain reaction) or the antibodies it provokes (serology), and Koch’s postulates cannot be satisfied in the classical way for a virus, because the agent cannot be cultured alone.

Take the four criteria one at a time and the paradox turns into a set of practical consequences. Growth: a cell grows by taking in material and enlarging before it divides, but a virion is assembled in its mature form — host ribosomes translate viral messenger RNA into coat proteins, which self-assemble around a copied genome and, for enveloped viruses, bud through a cell membrane — so there is no juvenile stage and no change in size to measure. In the laboratory this means a virus cannot be counted as colonies on a plate; infectivity is measured by a plaque assay, in which serial dilutions of a sample are placed on a lawn of living host cells and each infectious particle produces a clear zone of destroyed cells, so one plaque is read as one infectious unit. Metabolism: a virion has no ribosomes, no membrane transport and no energy-generating pathway of its own, and it consumes no nutrients outside a cell. This single fact explains why antibiotics never cure a viral illness: antibiotics act on structures unique to bacteria, such as the peptidoglycan wall, the 70S ribosome or a bacterial folate pathway, none of which a virion possesses. Antiviral drugs must instead block a viral enzyme or a step in entry — a polymerase, a protease, a neuraminidase or an integrase — which is why they are few in number and why each one acts on a narrow range of viruses. Reproduction: a virus does not divide; it runs a replication cycle of attachment, penetration, uncoating, synthesis, assembly and release. During the eclipse period no infectious particle can be recovered from the cell, because the virion has been taken apart and only its genome is still active. One infected cell can then release hundreds or thousands of progeny — the burst size — and because viral RNA polymerases usually lack proofreading, each round of copying introduces errors. That error rate is the raw material for the antigenic drift that lets influenza escape last year’s immunity, and for the drug resistance that appears during HIV treatment. Response to stimuli: a virion does not hunt, sense or swim towards a cell; attachment is a chemical fit between a viral surface protein and a host receptor, like a key in a lock. No receptor means no infection, which is much of the explanation for host range and for tissue tropism, as when influenza haemagglutinin binds sialic acid residues on respiratory epithelium or HIV gp120 binds the CD4 receptor of helper T cells. Put the four together and the verdict is clear: by growth, metabolism, reproduction and response to stimuli, a virus is not alive. Yet it carries a genome, it replicates, it mutates and it is selected, so it is unquestionably biological. The argument about whether viruses are alive is therefore largely a question of definition rather than a fact about nature, and the nurse should hold both halves at once: not a cell, but a threat. The practical translation at the bedside is four habits — never expect an antibiotic to cure a viral illness, start antivirals early because they act on steps that happen in the first days, monitor viral load rather than culture when judging HIV treatment, and rely on hand hygiene, isolation and vaccination, which interrupt a particle that cannot multiply on its own.